Iloperidone cas: 133454-47-4

CAS NO: 133454-47-4
Iloperidone
Description Review
Description

Iloperidone cas: 133454-47-4 is a medication used in the treatment of schizophrenia. It is an atypical antipsychotic that works by blocking the action of dopamine and serotonin receptors in the brain, leading to a reduction in psychotic symptoms.

Chemical name:

Iloperidone

Molecular formula:

C24H27FN2O4

Formula weight:

426.49 g/mol

CAS No:

133454-47-4

Top ten keywords from Google and synonyms:

  1. Schizophrenia
  2. Atypical antipsychotic
  3. Dopamine receptor
  4. Serotonin receptor
  5. Psychotic symptoms
  6. Neuroleptic
  7. Mental illness
  8. Antipsychotic medication
  9. Neurotransmitter
  10. Mental health

Synonyms:

Fanapt | Zomaril | Iloperidona [INN-Spanish] | Q-15 | 1-(4-Fluorobenzyl)-4-(3-(4-methylpiperazin-1-yl)propoxy)benzoic acid | Iloperidone (JAN/USAN) | UNII-U4X4K4V67N | Iloperidoni hydrochloridum [INN-Latin] | Iloperidone Hydrochloride | Iloperidone [USAN:INN] | Iloperidonum [INN-Latin]

Health benefits of this product:

Iloperidone is mainly used in the treatment of schizophrenia, a mental illness characterized by delusions, hallucinations, and disordered thinking. Treatment with atypical antipsychotics like iloperidone can significantly reduce psychotic symptoms and improve quality of life for individuals with schizophrenia.

Potential effects:

As an atypical antipsychotic, iloperidone works by blocking the action of dopamine and serotonin receptors in the brain. These neurotransmitters are responsible for regulating mood, perception, and behavior. By reducing the activity of these receptors, iloperidone can help alleviate psychotic symptoms in individuals with schizophrenia.

Product mechanism:

The exact mechanism of action of iloperidone is not fully understood, but it is believed to work by blocking the action of dopamine and serotonin receptors in the brain. These neurotransmitters are responsible for regulating mood, perception, and behavior, and are believed to be implicated in the development of psychotic symptoms in individuals with schizophrenia.

By reducing the activity of these receptors, iloperidone can help alleviate psychotic symptoms, including delusions, hallucinations, and disordered thinking.

Safety:

Iloperidone is generally considered safe when used as directed. However, like all medications, it may cause side effects in some individuals. It is important to speak with a healthcare provider before starting any new medication to ensure it is safe and appropriate for you.

Side effects:

Common side effects associated with iloperidone use include dizziness, drowsiness, dry mouth, and constipation. In some cases, it may cause more serious side effects, such as muscle stiffness, tremors, and difficulty swallowing. If you experience any unusual or severe side effects while taking iloperidone, contact a healthcare provider right away.

Dosing information:

The dosing of iloperidone will vary depending on the individual's condition and other factors. It is important to follow the dosing instructions provided by a healthcare provider carefully to ensure optimal treatment results.

Conclusion:

Iloperidone cas: 133454-47-4 is an important medication used in the treatment of schizophrenia. As an atypical antipsychotic, it works by blocking the action of dopamine and serotonin receptors in the brain, leading to a reduction in psychotic symptoms. While it is generally considered safe when used as directed, it may cause side effects in some individuals. As always, it is important to speak with a healthcare provider before starting any new medication to ensure it is safe and appropriate for you.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code